Epizyme, Inc

(NASDAQ:EPZM)

Latest On Epizyme, Inc (EPZM):

Date/Time Type Description Signal Details
2022-08-09 23:37 ESTNewsEpizyme GAAP EPS of -$0.21, revenue of $27.5MN/A
2022-08-05 17:40 ESTNewsIpsen extends tender offer date in Epizyme deal to get US antitrust clearance, required sharesN/A
2022-08-01 10:03 ESTNewsHutchmed begins dosing in mid-stage study of tazemetostat in blood cancer subtypeN/A
2022-07-06 05:12 ESTNewsEpizyme Acquisition By Ipsen: CVR ValueN/A
2022-06-27 07:57 ESTNewsEpizyme stock soars 60% as Ipsen set to acquire the cancer drugmakerN/A
2022-06-01 14:11 ESTNewsHutchmed, Epizyme cancer drug Tazverik gets China's Hainan province health regulator nodN/A
2022-05-11 03:06 ESTNewsEpizyme GAAP EPS of -$0.38 misses by $0.03, revenue of $8.69M misses by $1.33MN/A
2022-05-11 03:06 ESTNewsEpizyme, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-11 03:06 ESTNewsEpizyme, Inc. (EPZM) CEO Grant Bogle on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 05:10 ESTNewsEpizyme Q1 2022 Earnings PreviewN/A
2022-04-07 07:09 ESTNewsEpizyme chief medical officer Shefali Agarwal resignsN/A
2022-03-02 16:38 ESTNewsEpizyme, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 00:18 ESTNewsEpizyme GAAP EPS of -$0.49 misses by $0.08, revenue of $11.6M misses by $8.82MN/A
2022-03-02 00:18 ESTNewsEpizyme's (EPZM) CEO Grant Bogle on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-27 13:59 ESTNewsEpizyme raises $85M capital via stock offeringN/A
2022-01-27 13:58 ESTNewsEpizyme equity offering pummels stock as shares down 40%N/A
2022-01-20 03:39 ESTNewsEpizyme multiple myeloma candidate granted FDA Orphan Drug DesignationN/A
2022-01-10 18:54 ESTNewsEpizyme jumps after product revenue shows strong sequential growth: Q4 PrelimN/A
2021-11-25 19:30 ESTNewsEpizyme: Taking Advantage Of Recent Sell-OffN/A
2021-11-16 19:50 ESTNewsWarning: EPZM is at high risk of performing badlyN/A
2021-11-10 07:06 ESTNewsEpizyme, Inc. (EPZM) CEO Grant Bogle on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 08:00 ESTNewsEpizyme Q3 2021 Earnings PreviewN/A
2021-11-09 07:59 ESTNewsEpizyme EPS misses by $0.11, misses on revenueN/A
2021-11-04 08:09 ESTNewsFDA grants Fast Track status to Epizyme's lymphoma treatment EZM0414N/A
2021-08-10 03:16 ESTNewsEpizyme EPS misses by $0.02, beats on revenueN/A
2021-08-10 03:15 ESTNewsEpizyme CEO Robert Bazemore steps downN/A
2021-08-10 03:13 ESTNewsEpizyme, Inc. (EPZM) CEO Rob Bazemore on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-09 07:01 ESTNewsHutchmed inks Tazverik development deal with Epizyme in Greater ChinaN/A
2021-08-06 22:54 ESTNewsEpizyme Q2 Earnings PreviewN/A
2021-07-21 06:54 ESTNewsEpizyme gains as peer Constellation attracts sizable premium from MorphoSysN/A
2021-07-21 06:36 ESTNewsEpizyme: Potential Comeback With Tazemetostat After Initial Sales ChallengeN/A
2021-07-21 06:32 ESTNewsCircling Back On EpizymeN/A
2021-05-07 07:30 ESTNewsEpizyme, Inc. 2021 Q1 - Results - Earnings Call PresentationN/A
2021-05-06 11:05 ESTNewsEpizyme EPS misses by $0.12, beats on revenueN/A
2021-05-05 15:20 ESTNewsEpizyme Q1 2021 Earnings PreviewN/A
2021-03-30 05:29 ESTNewsEpizyme Comeback Is Likely, Price Makes It A BuyN/A
2021-03-16 23:36 ESTNewsEpizyme (EPZM) Presents At Barclays Global Healthcare Conference - SlideshowN/A
2021-03-16 23:36 ESTNewsEpizyme (EPZM) Presents At The Next EPIsode: Rewriting Oncology Treatment with Epigenetics - SlideshowN/A
2021-02-26 03:36 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.25 to $19.63.Neutral
2021-02-26 00:07 ESTNewsEpizyme downgraded at Morgan Stanley citing pandemic impactN/A
2021-02-25 03:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $22.25 to $21.25.Neutral
2021-02-24 15:31 ESTEarnings EstimateAn EPS average of -$1.55 is estimated for the 2022 year.Sell
2021-02-24 15:31 ESTEarnings EstimateAn EPS average of -$0.56 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-24 15:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $23 to $22.25.Neutral
2021-02-24 11:31 ESTFinancialsCompany financials have been released.Neutral
2021-02-23 13:37 ESTNewsEpizyme EPS misses by $0.06, beats on revenueN/A
2021-02-23 13:37 ESTNewsEpizyme Q4 top-line down 95%, Tazverik revenues reach $4.5MN/A
2021-02-23 13:37 ESTNewsEpizyme, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-23 13:36 ESTNewsEpizyme's (EPZM) CEO Rob Bazemore on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-22 20:18 ESTNewsEpizyme Q4 2020 Earnings PreviewN/A

About Epizyme, Inc (EPZM):

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops Tazemetostat in combination with rituximab in patients with follicular lymphoma; R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma (DLBCL); and PARP inhibitor in patients with platinum-resistant solid tumors, such as small-cell lung cancer, triple-negative breast cancer, and ovarian cancer. In addition, it develops Tazemetostat in patients with castration-resistant prostate cancer; and adults and pediatrics with INI1-negative tumors. Further, the company develops pinometostat for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; PRMT5 inhibitor for patients with solid tumors; and PRMT1 inhibitor. Epizyme, Inc. has collaboration agreements with Genentech Inc.; Glaxo Group Limited; Roche Molecular Systems, Inc.; Lymphoma Academic Research Organization; and Eisai Co. Ltd. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

EPZM Quotes by TradingView

See Advanced Chart

General

  • Name Epizyme, Inc
  • Symbol EPZM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 304
  • Fiscal Year EndDecember
  • IPO Date2013-05-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.epizyme.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 56.88
  • Price/Book (Most Recent Quarter) 6.08
  • Enterprise Value Revenue 50.89
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.29
  • Next Year EPS Estimate -$1.70
  • Next Quarter EPS Estimate -$0.65
  • Operating Margin -1430%
  • Return on Assets -31%
  • Return on Equity -90%
  • Revenue 15.76 million
  • Earnings Per Share -$1.86
  • Revenue Per Share $0.16
  • Gross Profit -100238000
  • Quarterly Earnings Growth 95%
View More

Highlights

  • Market Capitalization 903.85 million
  • EBITDA -143672992
  • Analyst Target Price $19.63
  • Book Value Per Share $1.46
View More

Share Statistics

  • Shares Outstanding 101.79 million
  • Shares Float 81.51 million
  • % Held by Insiders 392%
  • % Held by Institutions 95.29%
  • Shares Short 12.2 million
  • Shares Short Prior Month 11.86 million
  • Short Ratio 13.74
  • Short % of Float 16%
  • Short % of Shares Outstanding 12%
View More

Technicals

  • Beta 1.52
  • 52 Week High $22
  • 52 Week Low $8.76
  • 50 Day Moving Average 10.22
  • 200 Day Moving Average 11.77
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Epizyme, Inc (EPZM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Epizyme, Inc (EPZM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$8.38 million-$0.65-$0.59-10.24%
2020-09-302020-11-06$3.57 million-$0.55-$0.607.9%
2020-06-302020-08-04$N/A-$0.58-$0.638.05%
2020-03-312020-05-04$N/A-$0.51-$0.6926.5%
2019-12-312020-02-24$4.29 million-$0.59-$0.52-14.41%
2019-09-302019-10-30$5.72 million-$0.40-$0.4817.1%
2019-06-302019-08-09$5.9 million-$0.53-$0.51-4.41%
2019-03-312019-05-06$7.89 million-$0.39-$0.4512.38%
2018-12-312019-02-26$9.7 million-$0.29-$0.4940.7%
2018-09-302018-11-02$-12000000-$0.54-$0.6010.6%
2018-06-302018-08-02$12 million-$0.42-$0.5320.75%
2018-03-312018-05-08$N/A-$0.49-$0.549.78%
2017-12-312018-03-13$10 million-$0.51-$0.5710.64%
2017-09-302017-11-01$-10000000-$0.63-$0.664.02%
2017-06-302017-08-04$10 million-$0.48-$0.5411.86%
2017-03-312017-05-08$N/A-$0.56-$0.629.37%
2016-12-312017-03-09$478000-$0.60-$0.646.8%
2016-09-302016-11-03$6.58 million-$0.42-$0.6029.61%
2016-06-302016-08-08$473000-$0.49-$0.548.41%
2016-03-312016-05-09$472000-$0.41-$0.4916.29%
2015-12-312016-03-09$555000-$0.53-$0.6417.19%
2015-09-302015-11-09$358000-$0.56-$0.595.08%
2015-06-302015-08-06$736000-$0.63-$0.7010%
2015-03-312015-04-28$911000-$1.75-$0.99-76.77%
2014-12-312015-03-12$10.35 million-$0.44-$0.5316.98%
2014-09-302014-11-06$8.18 million-$0.58-$0.55-5.45%
2014-06-302014-08-13$9.49 million-$0.40-$0.5020%
2014-03-312014-05-13$13.39 million-$0.22-$0.4753.19%
2013-12-312014-02-27$36.32 million$0.52-$0.22336.36%
2013-09-302013-10-22$8.44 million-$0.34-$0.30-13.33%
2013-06-302013-07-31$14.84 million-$0.25-$0.3630.56%

Epizyme, Inc (EPZM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Epizyme, Inc (EPZM) Chart:

Epizyme, Inc (EPZM) News:

Below you will find a list of latest news for Epizyme, Inc (EPZM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Epizyme, Inc (EPZM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest EPZM Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$0.6767
Jun 13, 2022 7:59 PM EST53$0.6798
Jun 13, 2022 7:59 PM EST23$0.6736
Jun 13, 2022 7:59 PM EST16$0.6736
Jun 13, 2022 7:59 PM EST61$0.6798

Epizyme, Inc (EPZM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320018139/0000899243-20-018139-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000021545719003949/0000215457-19-003949-index.htm
2018-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000031506618002425/0000315066-18-002425-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000031506619001027/0000315066-19-001027-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000083423720005314/0000834237-20-005314-index.htm
2019-01-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319001987/0000899243-19-001987-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319002089/0000899243-19-002089-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319002090/0000899243-19-002090-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319002092/0000899243-19-002092-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319002093/0000899243-19-002093-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016008/0000899243-19-016008-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016010/0000899243-19-016010-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016012/0000899243-19-016012-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016013/0000899243-19-016013-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016017/0000899243-19-016017-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016018/0000899243-19-016018-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319016019/0000899243-19-016019-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319017098/0000899243-19-017098-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319017099/0000899243-19-017099-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319017101/0000899243-19-017101-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319017102/0000899243-19-017102-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319017213/0000899243-19-017213-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319018863/0000899243-19-018863-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319018867/0000899243-19-018867-index.htm
2019-08-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319022188/0000899243-19-022188-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319022189/0000899243-19-022189-index.htm
2019-09-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319022774/0000899243-19-022774-index.htm
2019-09-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319022777/0000899243-19-022777-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319022778/0000899243-19-022778-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319022780/0000899243-19-022780-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319024666/0000899243-19-024666-index.htm
2019-11-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319027022/0000899243-19-027022-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319027026/0000899243-19-027026-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924319028682/0000899243-19-028682-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320000246/0000899243-20-000246-index.htm
2020-01-074/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320000666/0000899243-20-000666-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320002109/0000899243-20-002109-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320002111/0000899243-20-002111-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320002113/0000899243-20-002113-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320002114/0000899243-20-002114-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320002116/0000899243-20-002116-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320003366/0000899243-20-003366-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320003368/0000899243-20-003368-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320003370/0000899243-20-003370-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320003372/0000899243-20-003372-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320003376/0000899243-20-003376-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320004530/0000899243-20-004530-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320007256/0000899243-20-007256-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320008847/0000899243-20-008847-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320009604/0000899243-20-009604-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320009605/0000899243-20-009605-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320009606/0000899243-20-009606-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320009607/0000899243-20-009607-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320009609/0000899243-20-009609-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320010006/0000899243-20-010006-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320010007/0000899243-20-010007-index.htm
2020-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320010131/0000899243-20-010131-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320010133/0000899243-20-010133-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014895/0000899243-20-014895-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014896/0000899243-20-014896-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014897/0000899243-20-014897-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014898/0000899243-20-014898-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014899/0000899243-20-014899-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014900/0000899243-20-014900-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014901/0000899243-20-014901-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014902/0000899243-20-014902-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014903/0000899243-20-014903-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320014907/0000899243-20-014907-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017444/0000899243-20-017444-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017446/0000899243-20-017446-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017802/0000899243-20-017802-index.htm
2020-06-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017854/0000899243-20-017854-index.htm
2020-06-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017858/0000899243-20-017858-index.htm
2020-06-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017863/0000899243-20-017863-index.htm
2020-06-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017865/0000899243-20-017865-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017900/0000899243-20-017900-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017901/0000899243-20-017901-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017902/0000899243-20-017902-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017904/0000899243-20-017904-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320017906/0000899243-20-017906-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320018118/0000899243-20-018118-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320018139/0000899243-20-018139-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320023197/0000899243-20-023197-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320024203/0000899243-20-024203-index.htm
2020-09-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320026390/0000899243-20-026390-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320026391/0000899243-20-026391-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320026674/0000899243-20-026674-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000089924320026675/0000899243-20-026675-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000093247119004471/0000932471-19-004471-index.htm
2019-07-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1571498/000107261319000226/0001072613-19-000226-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000110465919006819/0001104659-19-006819-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000110465920013797/0001104659-20-013797-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000110465920016329/0001104659-20-016329-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000110465920019079/0001104659-20-019079-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000110465920021837/0001104659-20-021837-index.htm
2020-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000110465920113553/0001104659-20-113553-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000114420419007942/0001144204-19-007942-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000114420419008074/0001144204-19-008074-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312518266704/0001193125-18-266704-index.htm
2018-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312518275235/0001193125-18-275235-index.htm
2018-10-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1571498/000119312518290910/0001193125-18-290910-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312518291511/0001193125-18-291511-index.htm
2018-10-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1571498/000119312518291985/0001193125-18-291985-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312518316333/0001193125-18-316333-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312518327200/0001193125-18-327200-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519001888/0001193125-19-001888-index.htm
2019-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519011513/0001193125-19-011513-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519050566/0001193125-19-050566-index.htm
2019-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1571498/000119312519051933/0001193125-19-051933-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519058820/0001193125-19-058820-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1571498/000119312519065756/0001193125-19-065756-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1571498/000119312519065758/0001193125-19-065758-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519067207/0001193125-19-067207-index.htm
2019-03-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1571498/000119312519067223/0001193125-19-067223-index.htm
2019-03-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1571498/000119312519067240/0001193125-19-067240-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1571498/000119312519109795/0001193125-19-109795-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1571498/000119312519109796/0001193125-19-109796-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519137456/0001193125-19-137456-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519164105/0001193125-19-164105-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519198973/0001193125-19-198973-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519217387/0001193125-19-217387-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519224528/0001193125-19-224528-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519237718/0001193125-19-237718-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519278307/0001193125-19-278307-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312519282499/0001193125-19-282499-index.htm
2019-11-18SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1571498/000119312519294020/0001193125-19-294020-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520001720/0001193125-20-001720-index.htm
2020-02-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1571498/000119312520043992/0001193125-20-043992-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520045439/0001193125-20-045439-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1571498/000119312520052854/0001193125-20-052854-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520098100/0001193125-20-098100-index.htm
2020-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1571498/000119312520110407/0001193125-20-110407-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520131670/0001193125-20-131670-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520159129/0001193125-20-159129-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520208713/0001193125-20-208713-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1571498/000119312520287345/0001193125-20-287345-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919118054445/0001209191-18-054445-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919119035599/0001209191-19-035599-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919119039142/0001209191-19-039142-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919119039546/0001209191-19-039546-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919119040298/0001209191-19-040298-index.htm
2019-09-114/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919119049187/0001209191-19-049187-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919119051783/0001209191-19-051783-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1571498/000120919120001089/0001209191-20-001089-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000130692319000007/0001306923-19-000007-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1571498/000130692320000010/0001306923-20-000010-index.htm
2018-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459018026360/0001564590-18-026360-index.htm
2019-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1571498/000156459019004237/0001564590-19-004237-index.htm
2019-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459019015798/0001564590-19-015798-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459019031018/0001564590-19-031018-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459019039135/0001564590-19-039135-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1571498/000156459020007398/0001564590-20-007398-index.htm
2020-04-07PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1571498/000156459020015593/0001564590-20-015593-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1571498/000156459020017214/0001564590-20-017214-index.htm
2020-05-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459020020616/0001564590-20-020616-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459020035748/0001564590-20-035748-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1571498/000156459020051653/0001564590-20-051653-index.htm
2018-08-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1571498/999999999718007495/9999999997-18-007495-index.htm
2018-08-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1571498/999999999718007496/9999999997-18-007496-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1571498/999999999719001415/9999999997-19-001415-index.htm
2019-05-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1571498/999999999719004771/9999999997-19-004771-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1571498/999999999720000566/9999999997-20-000566-index.htm
2020-02-18SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1571498/999999999720000738/9999999997-20-000738-index.htm

Epizyme, Inc (EPZM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Epizyme, Inc (EPZM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 392%
Institutional Ownership: 9529%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-06-27DAVID M MOTTDirectorSell52,473.0012.43652,134.440.00https://www.sec.gov/Archives/edgar/data/1571498/000120919119039546/0001209191-19-039546-index.htm
2020-01-24Joseph BeaulieuCorporate ControllerSell330.0024.638,127.901,042.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002111/0000899243-20-002111-index.htm
2019-06-25DAVID M MOTTDirectorSell52,472.0013.31698,648.94104,945.00https://www.sec.gov/Archives/edgar/data/1571498/000120919119039142/0001209191-19-039142-index.htm
2020-06-18Matthew RosOfficerBuy68,651.009.58657,676.58120,449.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2020-03-16Andrew R AllenDirectorBuy12,500.009.33116,625.0012,500.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320008847/0000899243-20-008847-index.htm
2020-01-23Joseph BeaulieuCorporate ControllerBuy875.001,372.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002111/0000899243-20-002111-index.htm
2020-02-03Robert B BazemorePresident & CEOBuy52,595.00137,263.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320003376/0000899243-20-003376-index.htm
2019-03-31DAVID M MOTTDirectorBuy1,891.0012.3923,429.4913,979.00https://www.sec.gov/Archives/edgar/data/1571498/000120919119035599/0001209191-19-035599-index.htm
2020-02-03PAOLO TOMBESIChief Financial OfficerBuy11,688.0014,990.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320003366/0000899243-20-003366-index.htm
2020-03-25PAOLO TOMBESIChief Financial OfficerSell1,243.0015.2818,993.0415,437.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009607/0000899243-20-009607-index.htm
2019-06-30DAVID M MOTTDirectorBuy1,868.0012.5523,443.4015,847.00https://www.sec.gov/Archives/edgar/data/1571498/000120919119040298/0001209191-19-040298-index.htm
2020-03-24PAOLO TOMBESIChief Financial OfficerBuy1,690.0016,680.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009607/0000899243-20-009607-index.htm
2019-09-30DAVID M MOTTDirectorBuy2,271.0010.3223,436.7218,118.00https://www.sec.gov/Archives/edgar/data/1571498/000120919119051783/0001209191-19-051783-index.htm
2019-12-31DAVID M MOTTDirectorBuy952.0024.6023,419.2019,070.00https://www.sec.gov/Archives/edgar/data/1571498/000120919120001089/0001209191-20-001089-index.htm
2020-03-31DAVID M MOTTDirectorBuy1,512.0015.5123,451.1220,582.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320010007/0000899243-20-010007-index.htm
2020-06-26PAOLO TOMBESIChief Financial OfficerSell1,805.0016.1529,150.7521,942.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017902/0000899243-20-017902-index.htm
2020-06-25PAOLO TOMBESIChief Financial OfficerBuy6,000.0023,747.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017902/0000899243-20-017902-index.htm
2020-06-18Robert B BazemorePresident & CEOSell10,000.0022.00220,000.00244,371.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017444/0000899243-20-017444-index.htm
2020-06-26Robert B BazemorePresident & CEOSell4,773.0016.1577,083.95250,098.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017904/0000899243-20-017904-index.htm
2020-03-24Robert B BazemorePresident & CEOBuy113,393.00250,656.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009605/0000899243-20-009605-index.htm
2020-03-25Robert B BazemorePresident & CEOSell3,285.0015.2850,194.80254,371.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009605/0000899243-20-009605-index.htm
2020-06-18Robert B BazemorePresident & CEOSell10,000.0022.00220,000.00254,371.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017444/0000899243-20-017444-index.htm
2020-06-25Robert B BazemorePresident & CEOBuy10,500.00254,871.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017904/0000899243-20-017904-index.htm
2020-03-24Robert B BazemorePresident & CEOBuy7,000.00257,656.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009605/0000899243-20-009605-index.htm
2020-06-18Robert B BazemorePresident & CEOBuy10,000.008.9889,800.00264,371.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017444/0000899243-20-017444-index.htm
2020-04-01Jeffery KutokChief Scientific OfficerBuy27,412.0027,412.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320010133/0000899243-20-010133-index.htm
2020-08-19PAOLO TOMBESIChief Financial OfficerBuy7,055.0028,997.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320023197/0000899243-20-023197-index.htm
2019-01-24Shefali AgarwalChief Medical OfficerBuy32,894.0032,894.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319002090/0000899243-19-002090-index.htm
2019-06-14Shefali AgarwalChief Medical OfficerSell1,195.0011.9714,304.1535,699.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017213/0000899243-19-017213-index.htm
2020-02-03Joseph BeaulieuCorporate ControllerBuy2,575.003,617.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320003368/0000899243-20-003368-index.htm
2020-03-03Joseph BeaulieuCorporate ControllerSell996.0022.1822,091.283,617.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320007256/0000899243-20-007256-index.htm
2019-01-24Matthew RosChief Operating OfficerBuy32,894.0036,217.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319002093/0000899243-19-002093-index.htm
2019-06-12Shefali AgarwalChief Medical OfficerBuy4,000.0036,894.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017101/0000899243-19-017101-index.htm
2019-03-31Kevin T ConroyDirectorBuy897.0012.3911,113.833,775.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319016012/0000899243-19-016012-index.htm
2019-06-13Matthew RosOfficerSell1,185.0012.1014,338.5039,032.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017099/0000899243-19-017099-index.htm
2019-06-12Matthew RosOfficerBuy4,000.0040,217.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017099/0000899243-19-017099-index.htm
2020-01-24Matthew RosOfficerSell1,847.0024.6445,510.0842,185.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002114/0000899243-20-002114-index.htm
2020-01-23Matthew RosOfficerBuy5,000.0044,032.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002114/0000899243-20-002114-index.htm
2019-06-30Kevin T ConroyDirectorBuy887.0012.5511,131.854,662.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319018863/0000899243-19-018863-index.htm
2020-06-26Joseph BeaulieuCorporate ControllerSell317.0016.155,119.554,838.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017906/0000899243-20-017906-index.htm
2020-03-25Joseph BeaulieuCorporate ControllerSell212.0015.283,239.364,961.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009609/0000899243-20-009609-index.htm
2019-06-13Joseph BeaulieuCorporate ControllerSell203.0012.102,456.30497.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017102/0000899243-19-017102-index.htm
2020-01-23PAOLO TOMBESIChief Financial OfficerBuy5,000.005,000.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002109/0000899243-20-002109-index.htm
2020-02-03Matthew RosOfficerBuy11,688.0051,478.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320003372/0000899243-20-003372-index.htm
2020-06-25Joseph BeaulieuCorporate ControllerBuy1,050.005,155.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017906/0000899243-20-017906-index.htm
2020-03-24Joseph BeaulieuCorporate ControllerBuy1,556.005,173.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009609/0000899243-20-009609-index.htm
2020-03-25Matthew RosOfficerSell1,243.0015.2818,993.0451,798.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009606/0000899243-20-009606-index.htm
2020-06-18Matthew RosOfficerSell41,063.0020.50841,791.5051,798.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2020-06-18Matthew RosOfficerSell68,651.0021.651,486,294.1551,798.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2020-06-18Matthew RosOfficerSell2,289.0022.0050,358.0051,798.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2019-06-26DAVID M MOTTDirectorSell52,472.0012.85674,176.0052,473.00https://www.sec.gov/Archives/edgar/data/1571498/000120919119039142/0001209191-19-039142-index.htm
2020-03-24Matthew RosOfficerBuy1,563.0053,041.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009606/0000899243-20-009606-index.htm
2020-06-18Matthew RosOfficerBuy2,289.0012.4528,498.0554,087.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2019-09-30Kevin T ConroyDirectorBuy1,078.0010.3211,124.965,740.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319024666/0000899243-19-024666-index.htm
2020-06-26Matthew RosOfficerSell2,728.0016.1544,057.2057,507.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017900/0000899243-20-017900-index.htm
2019-12-02Shefali AgarwalChief Medical OfficerBuy22,577.0058,276.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319028682/0000899243-19-028682-index.htm
2020-01-27Shefali AgarwalChief Medical OfficerSell2,630.0020.4453,757.2058,803.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002116/0000899243-20-002116-index.htm
2020-09-02Joseph BeaulieuCorporate ControllerSell543.0012.886,993.845,958.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320024203/0000899243-20-024203-index.htm
2020-06-25Matthew RosOfficerBuy6,000.0060,235.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017900/0000899243-20-017900-index.htm
2020-01-24Shefali AgarwalChief Medical OfficerSell1,843.0024.6445,411.5261,433.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002116/0000899243-20-002116-index.htm
2019-12-31Kevin T ConroyDirectorBuy452.0024.6011,119.206,192.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320000246/0000899243-20-000246-index.htm
2020-01-23Shefali AgarwalChief Medical OfficerBuy5,000.0063,276.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002116/0000899243-20-002116-index.htm
2018-10-05DAVID M MOTTDirectorBuy416,667.009.003,750,003.006,471,018.00https://www.sec.gov/Archives/edgar/data/1571498/000120919118054445/0001209191-18-054445-index.htm
2020-03-31Kevin T ConroyDirectorBuy717.0015.5111,120.676,909.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320010006/0000899243-20-010006-index.htm
2019-06-12Joseph BeaulieuCorporate ControllerBuy700.00700.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017102/0000899243-19-017102-index.htm
2020-02-03Shefali AgarwalChief Medical OfficerBuy12,856.0071,659.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320003370/0000899243-20-003370-index.htm
2020-03-25Shefali AgarwalChief Medical OfficerSell1,243.0015.2818,993.0471,991.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009604/0000899243-20-009604-index.htm
2020-03-24Shefali AgarwalChief Medical OfficerBuy1,575.0073,234.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320009604/0000899243-20-009604-index.htm
2019-03-31BETH C SEIDENBERGDirectorBuy1,024.0012.3912,687.367,471.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319016019/0000899243-19-016019-index.htm
2020-06-30Kevin T ConroyDirectorBuy693.0016.0611,129.587,602.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320018118/0000899243-20-018118-index.htm
2020-06-26Shefali AgarwalChief Medical OfficerSell1,805.0016.1529,150.7578,611.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017901/0000899243-20-017901-index.htm
2019-01-24Robert B BazemorePresident & CEOBuy75,383.0080,068.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319002089/0000899243-19-002089-index.htm
2020-06-25Shefali AgarwalChief Medical OfficerBuy6,000.0080,416.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017901/0000899243-20-017901-index.htm
2020-06-26DAVID M MOTTDirectorBuy62,019.0016.03994,164.5782,601.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017802/0000899243-20-017802-index.htm
2020-06-30DAVID M MOTTDirectorBuy1,459.0016.0623,431.5484,060.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320018139/0000899243-20-018139-index.htm
2020-01-27Robert B BazemorePresident & CEOSell6,074.0020.44124,152.5684,668.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002113/0000899243-20-002113-index.htm
2019-06-30BETH C SEIDENBERGDirectorBuy1,010.0012.5512,675.508,481.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319018867/0000899243-19-018867-index.htm
2019-06-13Robert B BazemorePresident & CEOSell2,074.0012.1025,095.4084,994.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017098/0000899243-19-017098-index.htm
2020-09-30Kevin T ConroyDirectorBuy933.0011.9311,130.698,535.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320026674/0000899243-20-026674-index.htm
2020-09-30DAVID M MOTTDirectorBuy1,965.0011.9323,442.4586,025.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320026675/0000899243-20-026675-index.htm
2019-06-12Robert B BazemorePresident & CEOBuy7,000.0087,068.00https://www.sec.gov/Archives/edgar/data/1571498/000089924319017098/0000899243-19-017098-index.htm
2020-01-24Robert B BazemorePresident & CEOSell3,002.0024.6273,909.2490,742.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002113/0000899243-20-002113-index.htm
2020-02-11Pablo G. LegorretaDirectorBuy2,500,000.0020.0050,000,000.009,166,667.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320004530/0000899243-20-004530-index.htm
2020-06-18Matthew RosOfficerBuy41,063.009.12374,494.5692,861.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320017434/0000899243-20-017434-index.htm
2020-01-23Robert B BazemorePresident & CEOBuy8,750.0093,744.00https://www.sec.gov/Archives/edgar/data/1571498/000089924320002113/0000899243-20-002113-index.htm